NO972764L - Anvendelse av strontiumsalter for fremstilling av farmasöytiske sammensetninger for behandling av artrose - Google Patents

Anvendelse av strontiumsalter for fremstilling av farmasöytiske sammensetninger for behandling av artrose

Info

Publication number
NO972764L
NO972764L NO972764A NO972764A NO972764L NO 972764 L NO972764 L NO 972764L NO 972764 A NO972764 A NO 972764A NO 972764 A NO972764 A NO 972764A NO 972764 L NO972764 L NO 972764L
Authority
NO
Norway
Prior art keywords
treatment
osteoarthritis
preparation
pharmaceutical compositions
strontium salts
Prior art date
Application number
NO972764A
Other languages
English (en)
Other versions
NO972764D0 (no
NO315840B1 (no
Inventor
Yannis Tsouderos
Pascale Deloffre
Michel Wierzbicki
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO972764D0 publication Critical patent/NO972764D0/no
Publication of NO972764L publication Critical patent/NO972764L/no
Publication of NO315840B1 publication Critical patent/NO315840B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
NO19972764A 1996-06-17 1997-06-16 Anvendelse av distrontiumsaltet av 2-[N,N- di(karboksymetyl)amino]-3-cyano-4-karboksymetyltiofen-5-karboksylsyre til fremstilling av etfarmasöytisk preparat for behandling av artrose NO315840B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9607475A FR2749759B1 (fr) 1996-06-17 1996-06-17 Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose

Publications (3)

Publication Number Publication Date
NO972764D0 NO972764D0 (no) 1997-06-16
NO972764L true NO972764L (no) 1997-12-18
NO315840B1 NO315840B1 (no) 2003-11-03

Family

ID=9493102

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972764A NO315840B1 (no) 1996-06-17 1997-06-16 Anvendelse av distrontiumsaltet av 2-[N,N- di(karboksymetyl)amino]-3-cyano-4-karboksymetyltiofen-5-karboksylsyre til fremstilling av etfarmasöytisk preparat for behandling av artrose

Country Status (16)

Country Link
US (1) US5856356A (no)
EP (1) EP0813869B1 (no)
JP (1) JP3935557B2 (no)
CN (1) CN1136856C (no)
AT (1) ATE233558T1 (no)
AU (1) AU711950B2 (no)
BR (1) BR9703603A (no)
CA (1) CA2206837C (no)
DE (1) DE69719408T2 (no)
DK (1) DK0813869T3 (no)
ES (1) ES2193337T3 (no)
FR (1) FR2749759B1 (no)
HU (1) HU227935B1 (no)
NO (1) NO315840B1 (no)
NZ (1) NZ328106A (no)
ZA (1) ZA975323B (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2846558B1 (fr) * 2002-11-05 2006-07-14 Servier Lab Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
WO2004084920A2 (en) * 2003-03-27 2004-10-07 Santosolve As Anti-inflammatory treatment based on strontium compounds
AU2004237437B2 (en) * 2003-05-07 2011-01-20 Osteologix A/S Controlled release composition containing a strontium salt
PL1534305T3 (pl) * 2003-05-07 2007-03-30 Osteologix As Leczenie zaburzeń chrząstek i kości solami strontu rozpuszczalnymi w wodzie
US20060275503A1 (en) * 2003-05-07 2006-12-07 Nordic Bone A/S Combination treatment with strontium for the prophylaxis and/or treatment of cartilage and/or bone conditions
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
KR101165614B1 (ko) * 2004-02-26 2012-07-18 오스테올로지스 에이에스 괴사성 골 질환의 예방 또는 치료에 사용하기 위한스트론튬 함유 화합물
EP1744770A2 (en) * 2004-05-06 2007-01-24 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
JP2008502609A (ja) * 2004-06-17 2008-01-31 オステオロジックス エイ／エス リウマチおよび関節性疾患の治療改善方法
CA2570503A1 (en) * 2004-06-17 2005-12-29 Osteologix A/S A method of improving the medical treatment of pain
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
BRPI0512357A (pt) 2004-06-25 2008-03-04 Strontin Aps composições compreendendo estrÈncio e vitamina d e usos destas
CN101018586B (zh) * 2004-06-25 2014-08-27 莫克瓦洛Spf有限公司 含锶和维生素d的组合物及其用途
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
ES2582942T3 (es) 2004-10-08 2016-09-16 Forward Pharma A/S Composiciones farmacéuticas de liberación controlada que comprenden un éster de ácido fumárico
US20080004344A1 (en) * 2004-11-10 2008-01-03 Aditech Pharma Ab Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
EP1855654A1 (en) * 2005-02-28 2007-11-21 Osteologix A/S Tablets comprising a high load of strontium
FR2899895B1 (fr) 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
DK2029184T3 (da) 2006-05-26 2011-05-02 Baxter Int Injicerbar fibrinsammensætning til knogleforstærkning
GB0612028D0 (en) * 2006-06-16 2006-07-26 Imp Innovations Ltd Bioactive glass
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
CN101204375B (zh) * 2006-12-19 2010-09-29 北京德众万全药物技术开发有限公司 一种雷奈酸锶干混悬剂
ES2573327T3 (es) * 2007-04-23 2016-06-07 Baxter International Inc. Composiciones de fibrina que contienen compuestos de estroncio
GB0713094D0 (en) * 2007-07-05 2007-08-15 Imp Innovations Ltd Glass polycarboxylate cements
GB0724556D0 (en) * 2007-12-17 2008-01-30 Queen Mary & Westfield College LAtency associated protein construct with aggrecanase sensitive cleavage site
US8642831B2 (en) 2008-02-29 2014-02-04 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US20110142902A1 (en) * 2008-05-27 2011-06-16 Imperial Innovations Limited Hypoxia Inducing Factor (HIF) Stabilising Glasses
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials
ES2411972T5 (es) 2009-01-09 2021-10-27 Fwp Ip Aps Formulación farmacéutica que comprende uno o más ésteres de ácido fumárico en una matriz de erosión
GB0911365D0 (en) 2009-06-30 2009-08-12 Bioceramic Therapeutics Ltd Multicomponent glasses for use as coatings and in personal care products
FR2953139B1 (fr) 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
EP2575770B1 (en) 2010-06-01 2017-03-22 Baxter International Inc Process for making dry and stable hemostatic compositions
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
CN103957948B (zh) 2011-10-11 2016-10-26 巴克斯特国际公司 止血组合物
WO2013053759A2 (en) 2011-10-11 2013-04-18 Baxter International Inc. Hemostatic compositions
KR101975624B1 (ko) 2011-10-27 2019-05-07 백스터 인터내셔널 인코포레이티드 지혈 조성물
US11109849B2 (en) 2012-03-06 2021-09-07 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
BR112014030962A2 (pt) 2012-06-12 2017-06-27 Ferrosan Medical Devices As métodos para preparação e para reconstituição de uma composição seca adequada para uso em hemostase e cicatrização de feridas, e, kit hemostático
EP3010419B1 (en) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
EP3206726B1 (en) 2014-10-13 2020-05-27 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
CN107206165B (zh) 2014-12-24 2020-10-23 弗罗桑医疗设备公司 用于保持并混合第一和第二物质的注射器
JP6747651B2 (ja) 2015-07-03 2020-08-26 フェロサン メディカル デバイシーズ エイ／エス 保管状態で真空を保持するための、及び２種の成分を混合するためのシリンジ
US10463636B2 (en) 2016-09-30 2019-11-05 Deanna J. Nelson Pharmaceutical quality strontium L-lactate
WO2019215274A1 (en) 2018-05-09 2019-11-14 Ferrosan Medical Devices A/S Method for preparing a haemostatic composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152431A (en) * 1977-09-22 1979-05-01 William H. Rorer, Inc. Compositions and method of use
FR2633619B1 (fr) * 1988-06-29 1991-02-08 Adir Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
NO972764D0 (no) 1997-06-16
HUP9701059A3 (en) 1998-05-28
CA2206837A1 (fr) 1997-12-17
ES2193337T3 (es) 2003-11-01
JP3935557B2 (ja) 2007-06-27
DK0813869T3 (da) 2003-06-02
ATE233558T1 (de) 2003-03-15
ZA975323B (en) 1998-01-14
JPH1059852A (ja) 1998-03-03
NZ328106A (en) 2001-04-27
NO315840B1 (no) 2003-11-03
DE69719408T2 (de) 2003-12-24
CN1136856C (zh) 2004-02-04
AU711950B2 (en) 1999-10-28
FR2749759A1 (fr) 1997-12-19
CN1179944A (zh) 1998-04-29
BR9703603A (pt) 1998-09-01
EP0813869A1 (fr) 1997-12-29
DE69719408D1 (de) 2003-04-10
HUP9701059A2 (hu) 1998-03-02
US5856356A (en) 1999-01-05
AU2490297A (en) 1998-01-08
CA2206837C (fr) 2002-12-03
FR2749759B1 (fr) 1999-11-26
HU9701059D0 (en) 1997-08-28
HU227935B1 (en) 2012-06-28
EP0813869B1 (fr) 2003-03-05

Similar Documents

Publication Publication Date Title
NO972764L (no) Anvendelse av strontiumsalter for fremstilling av farmasöytiske sammensetninger for behandling av artrose
SE9604786D0 (sv) New compounds
DE69117117D1 (de) Reinigungszusammensetzung zur Vorbeugung und Milderung von Hautreizungen
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
IE862554L (en) Pharmaceutical compositions
IL81887A0 (en) Dihydroisoxazole derivatives,their preparation and pharmaceutical compositions containing them
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
ES2052871T3 (es) Preparacion de bis (3,5-di-t-butil-4-hidroxifeniltio)metano.
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
NO914352L (no) Fremgangsmaate for behandling av brukte katodebunner
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
DE69806801D1 (de) Galenische präparation zur prävention und behandlung von hepatokarzinomen
DE59711379D1 (de) Oral applizierbare formulierungen von chinolon- oder naphthyridoncarbonsäuren
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
DE69512929D1 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
ATA903489A (de) Protoporphyrinogeninhibitoren und deren verwendung in zusammensetzungen zur erkennung und behandlung von tumoren
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
PT932400E (pt) Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica
DE59107536D1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
HU9700642D0 (en) Use of bradiquinine antagonists for producing pharmaceutical compositions for treating fibrogenetic and acut hepatopathias
HU9701606D0 (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psychointellectual disorders
ES2190499T3 (es) Uso de antagonistas de bradiquinina para la preparacion de medicamentos para el tratamiento y la prevencion de la enfermedad de alzheimer.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees